Rodgers Brothers Inc. Merck & Co., Inc. Transaction History

Rodgers Brothers Inc.

  • $704 Million
  • Q4 2024

A detailed history of Rodgers Brothers Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Rodgers Brothers Inc. holds 129,194 shares of MRK stock, worth $10.7 Million. This represents 1.83% of its overall portfolio holdings.

Number of Shares
129,194
Previous 110,497 16.92%
Holding current value
$10.7 Million
Previous $12.5 Million 2.42%
% of portfolio
1.83%
Previous 1.73%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
BUY
$96.31 - $114.76 $1.8 Million - $2.15 Million
18,697 Added 16.92%
129,194 $12.9 Million
Q3 2024

Nov 14, 2024
BUY
$111.15 - $128.97 $3.19 Million - $3.7 Million
28,688 Added 35.07%
110,497 $12.5 Million
Q2 2024

Aug 14, 2024
SELL
$123.8 - $132.96 $58,805 - $63,156
-475 Reduced 0.58%
81,809 $10.1 Million
Q1 2024

May 14, 2024
SELL
$113.24 - $131.95 $2.25 Million - $2.62 Million
-19,829 Reduced 19.42%
82,284 $10.9 Million
Q4 2023

Feb 13, 2024
BUY
$100.18 - $109.02 $2.31 Million - $2.52 Million
23,078 Added 29.2%
102,113 $11.1 Million
Q3 2023

Nov 13, 2023
BUY
$102.95 - $114.33 $953,008 - $1.06 Million
9,257 Added 13.27%
79,035 $8.14 Million
Q2 2023

Aug 14, 2023
BUY
$108.61 - $118.38 $938,173 - $1.02 Million
8,638 Added 14.13%
69,778 $8.05 Million
Q1 2023

May 15, 2023
BUY
$102.94 - $114.86 $212,262 - $236,841
2,062 Added 3.49%
61,140 $6.5 Million
Q4 2022

Feb 14, 2023
SELL
$87.44 - $112.11 $4,109 - $5,269
-47 Reduced 0.08%
59,078 $6.55 Million
Q3 2022

Nov 14, 2022
BUY
$84.53 - $94.96 $78,190 - $87,838
925 Added 1.59%
59,125 $5.09 Million
Q2 2022

Aug 15, 2022
SELL
$83.49 - $94.64 $2.08 Million - $2.36 Million
-24,956 Reduced 30.01%
58,200 $5.31 Million
Q1 2022

May 16, 2022
BUY
$73.51 - $82.4 $3,675 - $4,120
50 Added 0.06%
83,156 $6.82 Million
Q4 2021

Feb 14, 2022
SELL
$72.28 - $90.54 $494,322 - $619,203
-6,839 Reduced 7.6%
83,106 $6.37 Million
Q3 2021

Nov 15, 2021
BUY
$71.68 - $78.83 $71,680 - $78,830
1,000 Added 1.12%
89,945 $6.76 Million
Q2 2021

Aug 16, 2021
SELL
$70.31 - $77.77 $58,005 - $64,160
-825 Reduced 0.92%
88,945 $6.92 Million
Q1 2021

May 17, 2021
BUY
$68.86 - $81.11 $1.07 Million - $1.27 Million
15,600 Added 21.03%
89,770 $6.92 Million
Q4 2020

Feb 16, 2021
BUY
$71.77 - $79.65 $346,290 - $384,311
4,825 Added 6.96%
74,170 $6.07 Million
Q3 2020

Nov 13, 2020
BUY
$73.18 - $82.95 $798,613 - $905,233
10,913 Added 18.68%
69,345 $5.75 Million
Q2 2020

Aug 13, 2020
SELL
$70.42 - $80.13 $20,069 - $22,837
-285 Reduced 0.49%
58,432 $4.52 Million
Q1 2020

May 14, 2020
BUY
$63.36 - $87.82 $441,175 - $611,490
6,963 Added 13.45%
58,717 $4.52 Million
Q4 2019

Feb 13, 2020
BUY
$77.58 - $87.54 $61,288 - $69,156
790 Added 1.55%
51,754 $4.71 Million
Q3 2019

Nov 14, 2019
SELL
$76.08 - $82.93 $403,984 - $440,358
-5,310 Reduced 9.44%
50,964 $4.29 Million
Q2 2019

Aug 14, 2019
BUY
$69.84 - $81.59 $91,141 - $106,474
1,305 Added 2.37%
56,274 $4.72 Million
Q1 2019

May 15, 2019
SELL
$69.58 - $79.36 $106,526 - $121,500
-1,531 Reduced 2.71%
54,969 $4.57 Million
Q4 2018

Feb 14, 2019
BUY
$65.24 - $75.71 $7,306 - $8,479
112 Added 0.2%
56,500 $4.12 Million
Q3 2018

Nov 14, 2018
BUY
$57.69 - $67.84 $634 - $746
11 Added 0.02%
56,388 $4 Million
Q2 2018

Aug 14, 2018
BUY
$50.83 - $59.72 $158,335 - $186,027
3,115 Added 5.85%
56,377 $3.42 Million
Q1 2018

May 15, 2018
BUY
$50.96 - $59.23 $304,282 - $353,662
5,971 Added 12.63%
53,262 $2.9 Million
Q4 2017

Feb 14, 2018
BUY
$51.62 - $61.64 $1.33 Million - $1.59 Million
25,740 Added 119.44%
47,291 $2.66 Million
Q3 2017

Nov 08, 2017
BUY
$58.67 - $63.13 $1.26 Million - $1.36 Million
21,551
21,551 $1.38 Million

Others Institutions Holding MRK

# of Institutions
3,946
Shares Held
1.93B
Call Options Held
15.9M
Put Options Held
14.9M
View Full List

About Merck & Co., Inc.

MRK Quotes by TradingView
  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $210B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Rodgers Brothers Inc. Portfolio

Follow Rodgers Brothers Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rodgers Brothers Inc., based on Form 13F filings with the SEC.

News

Stay updated on Rodgers Brothers Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email